Skip to Main Content

Paper Details

Proteome screening of pleural effusions identifies galectin 1 as a diagnostic biomarker and highlights several prognostic biomarkers for malignant mesothelioma.
Mol Cell Proteomics
36
2014
Galectin 1, Malignant mesothelioma, aldo-keto reductase 1B10, apolipoprotein C-I, asbestos-induced cancer, benign mesotheliosis, cancer, candidate, galectin 1, lung adenocarcinoma, malignant mesothelioma, mesothelioma, metastatic carcinomas, myosin-VIIb, patients, superoxide, superoxide dismutase 2, tenascin C, thrombospondin
Author NameAffiliation
Filip MundtKarolinska Institutet
  • 1 - 1

Datasets

Dataset
Description
Source Link
ProteomeXchangeProteomics resources portalLink
ProteomeXchangeProteomics resources portalLink
ProteomeXchangeProteomics resources portalLink
ProteomeXchangeProteomics resources portalLink
ProteomeXchangeProteomics resources portalLink
ProteomeXchangeProteomics resources portalLink
ProteomeXchangeProteomics resources portalLink
ProteomeXchangeProteomics resources portalLink
ProteomeXchangeProteomics resources portalLink
ProteomeXchangeProteomics resources portalLink
ProteomeXchangeProteomics resources portalLink
ProteomeXchangeProteomics resources portalLink
ProteomeXchangeProteomics resources portalLink
ProteomeXchangeProteomics resources portalLink
ProteomeXchangeProteomics resources portalLink
Release 1.2